OpportunityTitle: Novel Approaches to Diagnosing Alzheimer&apos;s Disease and Predicting Progression (R01)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Description: This Funding Opportunity Announcement (FOA) encourages research applications to identify novel biomarkers to diagnose Alzheimer&#8217;s disease and to predict clinical course.
GrantorContactEmailDescription: helpdesk@od.nih.gov
GrantorContactText: eRA Commons Help Desk &lt;br/&gt;Monday to Friday 7 am to 8 pm ET &lt;br/&gt;Phone 1-866-504-9552